Publication date: Mar 24, 2025
To identify systemic barriers leading to health inequities and health promoters experienced peri- and post-COVID-19 that impacted the health outcomes of women residing in geopolitical borderland communities of southern Arizona. Community-directed interventions that improve community health were sought. In 2023, we collected survey, interview, and focus group data documenting reported healthcare access, safety, stress, and discrimination experienced by a community of predominantly Mexican-origin women. Community-based participatory research and intersectional approaches were utilized. Data were analyzed and translated through group consensus processes. Mental health was the most significant health concern, and social support was identified as the greatest promoter of health. A grounded theory model emerged depicting the overarching theme, Building Strength and Inclusion Through Connection During COVID-19 and describing lived experiences of the community. Ten community-directed intervention strategies were developed and disseminated to decision-makers for improved community health. Underrepresented border communities bear the undue burden of health inequity underpinned by restrictive immigration policies and exclusion to critical resources. As communities recover from the impacts of COVID-19, intervention and prevention efforts must include organic local knowledge that accelerates public health. This study is crucial for community health practice and policy and presents emergent grounded theory, community-led praxis processes leading to effective health improvement strategies, and five key insights that inform future studies and programs.
Concepts | Keywords |
---|---|
Healthcare | Community health |
Immigration | Community-based participatory research |
Mexican | Discrimination |
Underrepresented | Intersectionality |
Social support | |
Women |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 |
disease | MESH | health inequities |
drug | DRUGBANK | Pentaerythritol tetranitrate |
disease | IDO | intervention |